Pyxis Oncology, Inc. Shares Outstanding (Cover Page)
Pyxis Oncology, Inc. (PYXS) had Shares Outstanding (Cover Page) of 83.41 million shares as of 2026-08-12, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-12: Entity Common Stock, Shares Outstanding 83.41M shares.
- 2026-05-08: Entity Common Stock, Shares Outstanding 63.36M shares.
- 2026-03-20: Entity Common Stock, Shares Outstanding 62.83M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 62.26M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-12 | 83.41M shares 10-Q · filed 2026-08-13 |
| 2026-05-08 | 63.36M shares 10-Q · filed 2026-05-14 |
| 2026-03-20 | 62.83M shares 10-K · filed 2026-03-23 |
| 2025-10-31 | 62.26M shares 10-Q · filed 2025-11-03 |
| 2025-08-13 | 62.02M shares 10-Q · filed 2025-08-14 |
| 2025-05-14 | 61.95M shares 10-Q · filed 2025-05-15 |
| 2025-03-17 | 61.59M shares 10-K · filed 2025-03-18 |
| 2024-11-11 | 59.47M shares 10-Q · filed 2024-11-12 |
| 2024-08-13 | 58.94M shares 10-Q · filed 2024-08-14 |
| 2024-05-13 | 58.89M shares 10-Q · filed 2024-05-14 |
| 2024-03-20 | 58.13M shares 10-K · filed 2024-03-21 |
| 2023-11-06 | 44.32M shares 10-Q · filed 2023-11-07 |
| 2023-08-09 | 39.53M shares 10-Q · filed 2023-08-11 |
| 2023-05-10 | 38.25M shares 10-Q · filed 2023-05-11 |
| 2023-03-21 | 36.98M shares 10-K/A · filed 2023-05-10 |
| 2022-11-01 | 35.10M shares 10-Q · filed 2022-11-01 |
| 2022-08-15 | 32.83M shares 10-Q · filed 2022-08-15 |
| 2022-05-13 | 32.82M shares 10-Q · filed 2022-05-13 |
| 2022-03-29 | 32.84M shares 10-K · filed 2022-03-29 |
| 2021-11-12 | 32.76M shares 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |